![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/3/37/2-Bromo-MDA.svg/640px-2-Bromo-MDA.svg.png&w=640&q=50)
2-Bromo-4,5-methylenedioxyamphetamine
Substituted amphetamine psychedelic drug / From Wikipedia, the free encyclopedia
2-Bromo-4,5-methylenedioxyamphetamine (6-Bromo-MDA) is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the dose is listed as 350 mg and the duration unknown.[1] It produces stimulant effects but with no psychedelic or empathogenic action.[1] Very little data exists about its pharmacological properties, metabolism, and toxicity.
This article relies largely or entirely on a single source. (September 2019) |
Quick Facts Names, Identifiers ...
![]() | |
Names | |
---|---|
Preferred IUPAC name
1-(6-Bromo-2H-1,3-benzodioxol-5-yl)propan-2-amine | |
Other names
2-Bromo-4,5-methylenedioxyamphetamine 2-(2-Bromo-4,5-methylenedioxyphenyl)ethan-1-methyl-amine | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider |
|
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C11H17BrNO2 | |
Molar mass | 275.166 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Close